COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,241 Articles (22,733 medRxiv, 8,508 bioRxiv)

Most recent first Previous |  Page 1942: Articles 19411-19420  | Next

SARS-CoV-2 infecting the inner ear results in potential hearing damage at the early stage or prognosis of COVID-19 in rodents
Xue, X., Tian, Y., Miao, M., Wang, J., Tang, W., Wang, Y., Liu, J., Xu, H., Miao, J.
10.1101/2020.12.23.423942 — Posted: 2020-12-25
Exploring epitope and functional diversity of anti-SARS-CoV2 antibodies using AI-based methods
Dumet, C., Jullian, Y., Musnier, A., Riviere, P., Poirier, N., Watier, H., Bourquard, T., Poupon, A.
10.1101/2020.12.23.424199 — Posted: 2020-12-24
Berberine and obatoclax inhibit SARS-CoV-2 replication in primary human nasal epithelial cells in vitro
Varghese, F. S., van Woudenbergh, E., Overheul, G. J., Eleveld, M. J., Kurver, L., van Heerbeek, N., van Laarhoven, A., Miesen, P., den Hartog, G., de Jonge, M. I., van Rij, R. P.
10.1101/2020.12.23.424189 — Posted: 2020-12-24
Cell-type apoptosis in lung during SARS-CoV-2 infection
Liu, Y., Garron, T. M., Chang, Q., Su, Z., Zhou, C., Gong, E. C., Zheng, J., Yin, W., Ksiazek, T., Brasel, T., Jin, Y., Boor, P., Comer, J. E., Gong, B.
10.1101/2020.12.23.424254 — Posted: 2020-12-24
Real-time monitoring epidemic trends and key mutations in SARS-CoV-2 evolution by an automated tool
Xi, B., Jiang, D., Li, S., Lon, J. R., Bai, Y., Lin, S., Hu, M., Meng, Y., Qu, Y., Huang, Y., Liu, W., Du, H.
10.1101/2020.12.24.424271 — Posted: 2020-12-24
Experimental SARS-CoV-2 infection of bank voles - general susceptibility but lack of direct transmission
Ulrich, L., Michelitsch, A., Halwe, N., Wernike, K., Hoffmann, D., Beer, M.
10.1101/2020.12.24.424203 — Posted: 2020-12-24
Detection and molecular characterisation of SARS-CoV-2 in farmed mink (Neovision vision) in Poland
Rabalski, L., Kosinski, M., Smura, T., Aaltonen, K., Kant, R., Sironen, T., Szewczyk, B., Grzybek, M.
10.1101/2020.12.24.422670 — Posted: 2020-12-24
Remdesivir-Ivermectin combination displays synergistic interaction with improved in vitro antiviral activity against SARS-CoV-2
Jeffreys, L., Pennington, S. H., Duggan, J., Breen, A., Jinks, J., Ardrey, A., Donnellan, S., Patterson, E. I., Hughes, G. I., Hong, W. D., O'Neill, P. M., Aljayyoussi, G., Owen, A., Ward, S. A., Biagini, G.
10.1101/2020.12.23.424232 — Posted: 2020-12-24
Inferring Toll-Like Receptor induced epitope subunit vaccine candidate against SARS-CoV-2: A Reverse Vaccinology approach
Nayak, A., Gadnayak, A., Sahoo, M., Bhairappanavar, S. B., Rout, B., Mohanty, J. N., Das, J.
10.1101/2020.12.24.424322 — Posted: 2020-12-24
HLA-C* 04:01 is a Genetic Risk Allele for Severe Course of COVID-19
Weiner, J., Suwalski, P., Holtgrewe, M., Thibeault, C., Mueller, M., Patriki, D., Quedenau, C., Krueger, U., Helbig, E. T., Lippert, L., Stubbemann, P., Real, L. M., Sanchez, J. M., Pineda, J. A., Fernandez-Fuertes, M., Wang, X., Karadeniz, Z., Saccomanno, J., Doehn, J.-M., Hubner, R.-H., Hinzmann, B., Salvo, M., Blueher, A., Siemann, S., Jurisic, S., Beer, H., Rutishauser, J., Wiggli, B. J., Schmid, H. R., Danninger, K., Binder, R., Corman, V. M., Muehlemann, B., Braun, A., Ripke, S., Jones, T. C., Suttorp, N., Witzenrath, M., Hippenstiel, S., Zemojtel, T., Skurk, C., Poller, W., Borodina, T., Pa-COVID Study Group, , Sander, L. E., Beule, D., Landmesser, U., Guettouche, T., Kurth, F., Heidecker, B.
10.1101/2020.12.21.20248121 — Posted: 2020-12-24 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).